We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Shares Clinical Trial Considerations for Diabetic Foot Infection Drugs
FDA Shares Clinical Trial Considerations for Diabetic Foot Infection Drugs
The FDA’s new draft guidance provides recommendations on overall development programs for drugs to treat diabetic foot infections (DFI) as well as clinical trial designs.